Your browser doesn't support javascript.
loading
Rituximab in primary Sjögren's syndrome: a ten-year journey.
Carubbi, F; Alunno, A; Cipriani, P; Bartoloni, E; Ciccia, F; Triolo, G; Gerli, R; Giacomelli, R.
Afiliación
  • Carubbi F; Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila, Italy francescocarubbi@libero.it.
  • Alunno A; Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy.
  • Cipriani P; Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila, Italy.
  • Bartoloni E; Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy.
  • Ciccia F; Department of Internal Medicine, Division of Rheumatology, University of Palermo, Palermo, Italy.
  • Triolo G; Department of Internal Medicine, Division of Rheumatology, University of Palermo, Palermo, Italy.
  • Gerli R; Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy.
  • Giacomelli R; Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L'Aquila, L'Aquila, Italy.
Lupus ; 23(13): 1337-49, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25096066

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Síndrome de Sjögren / Anticuerpos Monoclonales de Origen Murino / Factores Inmunológicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Síndrome de Sjögren / Anticuerpos Monoclonales de Origen Murino / Factores Inmunológicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Italia